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ABSTRACT
Introduction Intermittent neurogenic claudication (INC) is 
often caused by lumbar spinal stenosis (LSS). Laminectomy 
is considered a frequently used surgical technique for 
LSS. Previous studies have shown that laminectomy 
can potentially cause lumbar instability. Less invasive 
techniques, preserving midline structures including 
the bilateral small size interarcuair decompression, are 
currently applied. Due to lack of evidence and consensus, 
surgeons have to rely on their training and own experiences 
to choose the best surgical techniques for their patients. 
Hence, an observer and patient blinded multicentre, 
randomised controlled trial was designed to determine the 
effectiveness and cost- effectiveness of bilateral interarcuair 
decompression versus laminectomy for LSS.
Methods and analysis 174 patients above 40 years 
with at least 12 weeks of INC will be recruited. Patients 
are eligible for inclusion if they have a clinical indication 
for surgery for INC with an MRI showing signs of LSS. 
Patients will be randomised to laminectomy or bilateral 
interarcuair decompression. The primary outcome is 
functional status measured with the Roland- Morris 
Disability Questionnaire at 12 months. Secondary 
outcomes consist of pain intensity, self- perceived recovery, 
functional status measured with the Oswestry Disability 
Index and a physical examination. Outcome measurement 
moments will be scheduled at 3 and 6 weeks, and at 3, 
6, 12, 18, 24, 36 and 48 months after surgery. Physical 
examination will be performed at 6 weeks, and 12, 24 and 
48 months. An economic evaluation will be performed and 
questionnaires will be used to collect cost data.
Ethics and dissemination The Medical Ethical 
Committee of the Erasmus Medical Centre Rotterdam 
approved this study (NL.65826.078.18). The results will be 
published in an international peer- reviewed journal.
Trial registration number  ClinicalTrials. gov 
(NCT03480893).
IRB approval status MEC-2018-093.
INTRODUCTION
Lumbar spinal stenosis (LSS) is described as 
the narrowing of the diameter of the spinal 
and nerve root canals, which can cause 
compression of the neural structures in the 
canals.1 LSS is a common medical condition 
in the ageing population and is considered the 
most common reason for lumbar spine surgery 
for people over the age of 65.2–4 Intermittent 
neurogenic claudication (INC) is the most 
important symptom of LSS, with leg pain and 
heaviness of the legs, usually bilateral, which 
exacerbate during standing and walking. Apart 
from leg pain, back pain is often also present.5 
As the symptoms aggravate, the ability to walk 
can become considerably limited, which is the 
Strengths and limitations of this study
 ► Patient and observer blinded randomised controlled 
design.
 ► Both patient- reported outcomes and objective func-
tional test outcomes will be measured.
 ► Inclusion of an economic evaluation.
 ► Instability as outcome may not be measurable in 
2 years of follow- up.
 ► Diversity in terminology on posterior decompression 
techniques may lead to variability on both surgical 
techniques.
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dominant functional impairment and the most common 
reason for seeking medical care.6 7
Conservative treatment, such as physical therapy and pain 
medication, is the first treatment option and may give some 
relief of symptoms.8 Previous research shows that there is 
sparse evidence of the effectiveness of surgery compared 
with non- operative treatment.9 However, usually when 
conservative treatment fails, surgical treatment is considered 
the next option.10 11 The first technique described to widen 
the lumbar spinal canal is the laminectomy technique, also 
known as wide bony decompression, which is a widely used 
surgical technique for patients with INC caused by LSS.12 
Given that patients often experience postoperative back 
pain after laminectomy, it is hypothesised that laminectomy 
is a ground for potential lumbar instability and iatrogenic 
scoliosis.13–15 Performing a procedure with potentially more 
complications in an elderly population could be considered 
as doubtful. Hence, less invasive techniques, such as the 
bilateral small size interarcuair decompression, otherwise 
known as a bilateral laminotomy, limited bony decompres-
sion or interlaminar decompression, were developed and 
implemented in clinical practice. These techniques require 
less bone tissue to be removed, which possibly can reduce 
the prevalence of lumbar instability in these patients and 
consequently improve functioning.16 Furthermore, it is 
believed that, compared with laminectomy, these less inva-
sive techniques have the ability to decompress the nerves 
while preserving the spinal integrity. However, the risk of 
an insufficient decompression may be higher, possibly 
resulting in reoperations due to residual stenosis.16–18
The presumption is often made that, after a wide 
decompression, recurrence of the complaints is scarce. 
The opinions on this matter are diverse and subject to 
debate.19 Therefore, a randomised controlled trial (RCT) 
is needed to clarify whether bilateral interarcuair decom-
pression is effective and cost- effective compared with a 
classical laminectomy.
Study objectives
The primary objective of this study is to determine 
whether bilateral interarcuair decompression is more 
effective than laminectomy in patients with INC caused 
by LSS. The secondary objective is to evaluate if bilateral 
interarcuair decompression is more cost- effective than 
laminectomy.
Study design
The study is designed as a multicentre, patient and 
observer blinded RCT with an economic evaluation 
alongside. Participants will be allocated to one of the two 
groups: laminectomy or interarcuair decompression.
METHODS
Study setting/population
In total 174 patients with an MRI- confirmed LSS will be 
recruited. All patients who will be included should have 
an indication for surgery due to LSS with minimally 12 
weeks of INC, as is customary in clinical practice, and 
failed conservative treatment. Patients will be recruited 
from two hospitals and one private health clinic in the 
Netherlands:
 ► Erasmus Medical Centre (MC) in Rotterdam.
 ► Maasstad Hospital in Rotterdam.
 ► Park MC in Rotterdam.
Eligibility criteria
In order to be suitable to participate in this study, patients 
must meet all of the following criteria:
Inclusion criteria
 ► At least 12 weeks of INC with a leg pain level above 3 
on a Numeric Rating Scale (NRS), without sufficient 
response to conservative management.
 ► Indication for an operation according to consensus 
of surgeon.
 ► MRI demonstrating LSS.
 ► Age above 40 years.
 ► Sufficient knowledge of the Dutch language in order 
to comprehend the questionnaires and patient 
information.
 ► Written informed consent.
Exclusion criteria
Patients who meet any of the following criteria will be 
excluded from participating in this study.
 ► History of lumbar spine surgery.
 ► More than two lumbar levels needing surgery.
 ► Degenerative spondylolisthesis greater than Meyer-
ding grade I (on a scale of I–V).20 21
 ► Concomitant scoliosis or disc herniation.
 ► Severe comorbid medical disorder (American Society 
of Anesthesiologists >3).
 ► Serious psychopathological disorder.
 ► Pregnancy.
 ► Active malignancy.
 ► Plans to move abroad during study period.
Eligible patients will be randomised in a 1:1 ratio to the 
two groups.
Interventions
Intervention: bilateral small size interarcuair decompression
The intervention consists of the interarcuair decompres-
sion, otherwise known as a bilateral laminotomy, limited 
bony decompression or an interlaminar decompression. 
General anaesthesia is to be administered. A midline skin 
incision is made, after which the paravertebral muscles 
are dissected subperiosteally and retracted bilaterally. 
Decompression will be applied through decompression 
of the ligamentum flavum and partial laminotomy if 
necessary. The lateral recess will be opened bilaterally 
and a partial medial facetectomy will be performed to 
decompress neuronal structures including the exciting 
nerve root. The lamina will be removed up to the liga-
mentum flavum. Interspinous ligaments are spared.22 
The wound is closed in layers. Patients are operated with 
a loupe magnification or microscope depending on the 
surgeon’s preference.
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Control group: conventional laminectomy
The control group consists of conventional laminectomy, 
otherwise known as wide bony decompression. General 
anaesthesia is to be administered. A midline skin incision 
is made over the spinous processes. The laminae of the 
affected level(s) are exposed subperiosteally, and the 
supraspinous ligament is incised. The spinous process 
is removed. The supraspinous and interspinous liga-
ment of the affected level is removed by drill or Kerrison 
punched. Both laminae are removed at the affected level, 
leaving the facet joint intact. The lateral recess is opened 
bilaterally and a partial medial facetectomy will be 
performed to decompress neuronal structures including 
the exciting nerve root.16 To clarify, when a single level 
stenosis is present (eg, L4–L5), both laminae L4 and L5 
will be removed. When a double level stenosis (eg, L3–L4 
and L4–L5) is present, three laminae (L3, L4 and L5) 
will be removed. The wound is closed in layers with or 
without a suction drain. Patients will be operated with 
loupe magnification or microscope depending on the 
surgeon’s preference.
Use of co-intervention
Pain medication will be provided to patients after surgery, 
should this be necessary. Further, the use of co- interven-
tions will be tracked by cost questionnaires, in which 
medication usage and any healthcare utilisation is moni-
tored throughout the follow- up period.
Outcomes
Primary outcomes
The primary outcome is a functional status measured using 
the Roland- Morris Disability Questionnaire (RMDQ). 
This is a 24- point questionnaire that is designed to assess 
the functional status in patients with low back pain. This 
outcome measure has been identified as one of the most 
commonly used outcomes in a population with chronic 
low back pain.23–27
Secondary outcomes
Oswestry Disability Index
The Oswestry Disability Index (ODI) is one of the prin-
cipal condition- specific outcome measures used in the 
management of spinal disorders.28 The current V.2.1a will 
be used.29 It consists of 10 questions, each with 6 possible 
answers and each answer option receives a score of 0–5 
points, yielding a score range between 0 and 50, which is 
scaled to a 100% range. The questions focus on a range 
of daily physical functions and how the back or leg pain is 
affecting the patient’s ability to manage in everyday life.
NRS for leg and low back pain
This parameter will measure the experienced pain inten-
sity in both legs (affected and non- affected) and back. 
Pain intensity will be rated on an 11- point scale, varying 
from 0 representing ‘no pain’ to 10 ‘the most terrible 
pain imaginable’. Patients are not permitted to see the 
pain score indicated during previous visits. Reliability and 
validity of NRS have been shown.30
Short form 36
The quality of life will be measured with the Dutch 
version of the Short Form 36 (SF-36). The SF-36 has 
been applied and successfully validated in populations 
with low back pain.31 This questionnaire relates to the 
analysis of the general functional status of the patient. 
The questionnaire is divided into eight health concepts: 
(1) physical functioning, (2) role limitations because 
of physical health problems, (3) bodily pain, (4) social 
functioning, (5) general mental health (psychological 
distress and well- being); (6) emotional role limitations; 
(7) vitality and (8) general health perceptions. The scores 
of the different health concepts are added up into a scale 
of 0–100. A higher score reflects a better general health 
condition. The physical and mental component summary 
will be assessed separately.
Patients’ perceived recovery
Recovery will be measured using a 7- point Likert scale. 
The score on this scale varies from ‘complete recovery’ 
to ‘worse than ever’. The outcomes ‘complete recovery 
and ‘almost complete recovery’ will be dichotomised and 
considered as recovered.32
Patients’ satisfaction
Patients’ satisfaction of change and satisfaction of treat-
ment will be assessed using a 7- point Likert scale, ranging 
from ‘completely satisfied’ to ‘completely dissatisfied’. 
‘Completely satisfied’ and ‘almost completely satisfied’ 
will be defined as good outcome.
Physical examination
A physical examination will be performed before surgery, 
at 6 weeks, 12, 24 and 48 months after surgery. This exam-
ination will include a brief neurological examination, the 
Timed Up and Go Test (TUG), the Timed Chair- Stand 
Test (TCST), the 6- Minute Walking Test (6MWT) and 
patient’s weight.
A. Neurological examination
The neurological examination will include the mus-
cle strength of the quadriceps, the iliopsoas, the ham-
strings, the gastrocnemicus and the tibialis anterior 
muscle, which will be noted as a difference in strength 
between both legs. We will evaluate if there is a differ-
ence in muscle strength between the affected leg and 
the other leg.
B. TUG
Patients are asked to sit in a chair with their arms 
resting on the armrests. On direction of the research 
nurse, patients have to walk as fast as possible (without 
running) to a wall at 3 m distance of the chair. When 
they have reached that wall, a turn of 180° is made and 
they walk directly back to the chair and sit down. The 
research nurse will measure the time
(in seconds) it takes for a patient, to perform this ac-
tion. The time is stopped when the patients are seated 
again.33 Patients need to perform this test, three times. 
Patients are allowed to wear their regular shoes and 
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use a walking aid, if necessary. The TUG test has been 
described as a valid, reliable tool in the assessment of 
objective functional impairment in patients with lum-
bar degenerative disc disease.34 35 However, this has 
not been done for LSS. The validation for LSS will be 
conducted in this study.
C. TCST
Patients are asked to sit down on an armless chair, 
firmly placed against a wall, with their arms folded 
across their chest. They are instructed to place their 
feet flat on the ground. To become familiarised with 
the exercise, the patients are asked to stand up and sit 
down again without using their arms. If assistance is 
required during this action, or this movement cannot 
be completed by the patient, the test is abandoned. If 
the manoeuvre is possible, the patient will be asked to, 
on the word ‘go’, stand up entirely and sit down again, 
five times as quick as possible. The research nurse will 
time the five movements in seconds from the com-
mand ‘go’ to the completed fifth stand. The measured 
time will be noted as the score. If the patient is unable 
to perform the test five times, a maximum score will be 
noted of 30 s.36 37
D. 6MWT
This test is performed to assess the gait pattern, walk-
ing speed and physical endurance of patients. The 
patient will be requested to walk at such a speed that 
at the end of 6 min, the patient will have the feel-
ing of maximum output.38 Before taking the test, the 
patient will be given the instructions to install the 
6MWT application on their cell phone.39 40 During 
these 6 min this application will measure the walking 
distance. During the walking test, the patient is per-
mitted to use a walking aid and/or orthosis which 
will be noted.
Functional lumbar X-rays
Functional X- rays will be obtained from all patients. The 
X- ray will be made standing from Antero- posterior and 
lateral position to assess spondylolisthesis. X- rays will 
also be made in maximum flexion and extension posi-
tion. Degenerative spondylolisthesis is defined as a verte-
bral slip of at least 3 mm.41 After the measurement of 
the vertebral slip, this will be classified according to the 
Meyerding classification. This will be obtained at 6 weeks 
postoperatively, for level verification and for verification 
of correct procedure and after 2 years postoperatively to 
look for possible instability.
EuroQol-5-dimension-5-levels
The EuroQol-5- dimension-5- levels (EQ- 5D- 5L) is a vali-
dated instrument to assess health- related quality of life. 
The tool measures five dimensions:
 ► Mobility.
 ► Self- care.
 ► Pain/discomfort.
 ► Daily activities.
 ► Anxiety.
Each dimension consists of one item, in which five 
levels are distinguished (no problems, minor problems, 
moderate problems, major problems, severe problems, 
unable to). The Dutch tariff of the EQ- 5D- 5L will be used 
to calculate the quality- adjusted life years (QALYs).42 43
Cost-diaries
Based on a diary with made costs, which will be completed 
by patients, insight will be obtained in the need for care, 
working participation and direct and indirect medical 
cost. Direct medical cost will be estimated on basis of the 
cost centre method. In addition it is expected that the 
study population will consist of elderly people who may 
be retired. For the cost calculation additional costs, such 
as help in house, transport and help from family will be 
taken into account.
For an estimation of direct and indirect cost, permis-
sion of the patient will be asked to request the total 
amount of cost incurred during the research period 
from the insurance company. No consideration by 
participation in the investigation as compared with daily 
practice will be deducted. The additional investigational 
costs include mainly the additional visits to the outpa-
tient clinic.
The patient will be requested to keep a diary for the 
financial aspects of the consequences of INC and corre-
sponding treatment. The patient will be requested to 
record the following items:
 ► Visits to general practitioner.
 ► Visits to physiotherapist.
 ► Visits to specialist.
 ► Alternative medicines and devices (eg, rollator).
 ► Number of days of hospitalisation.
 ► Pain medication; dosage and frequency.
 ► Illness- related days of absence at work, if any.
 ► Cost of loss production and substitute manpower, if 
any.
 ► Additional travelling expenses on account of INC.
 ► Help in house holding.
Complication and reoperation incidence
Immediately after surgery, the surgeon will report any 
perioperative complications such as cerebrospinal fluid 
leakage, nerve root damage and if the operation was 
implemented at the wrong vertebral level. Additionally, a 
systematic assessment of complications (including urinary 
tract infection, progressive neurological deficit and 
secondary bleeding) will be carried out by the surgeon 
and the research nurse shortly after discharge.
Reoperation is considered a bad outcome. The inci-
dence of reoperation as well as perioperative morbidity 
will be assessed in both groups, using surgical parameters 
such as blood loss, time of surgery and length of hospital 
stay.
We used the Standard Protocol Items: Recommenda-
tions for Interventional Trials checklist when writing our 
report.44
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Patient and public involvement
No patients involved.
Sample size
The sample size of this study is calculated for the primary 
endpoint of group difference in the RMDQ at 12 months. 
According to literature, results obtained after interarcuair 
decompression should be 3 points lower on the RMDQ 
compared with those for the laminectomy group in order 
to detect superiority.45
Hence, the sample size of this study is based on a supe-
riority design, using a delta of 3, an assumed true mean 
difference of 0 and a pooled SD of 6. Using an alpha of 
0.05, and a power of 90%, we calculated a sample size 
of 69 patients per group. Accounting for a 20% loss in 
follow- up, we will therefore enrol 174 patients (87 patients 
per group).
Allocation
Computerised block randomisation will take place after 
the patient has been anaesthetised. Allocation conceal-
ment will be assured by using ALEA, a web- based data 
system supervised by the Clinical Trial Centre of the 
Erasmus MC. Variable block sizes of 4, 6 and 8 will be 
used and stratified by treatment centre. Patients will be 
randomised in a 1:1 ratio to laminectomy or bilateral 
interarcuair decompression. Each patient will be given a 
unique study number.
Blinding
All researchers and patients will be blinded for the treat-
ment. This is possible, because there are no fundamental 
differences between both procedures (eg, general anaes-
thesia, spinal incision, inpatient procedure). The statis-
tical analyses will be performed blinded. The surgeon 
cannot be blinded.
Data collection methods
All patient reported outcomes will be collected preopera-
tively and after 3 weeks, 6 weeks, 3 months, 6 months, 12 
months, 18 months, 24 months, 36 months and 48 months 
(see table 1). Patients will receive an email with a link, 
reminding them of the upcoming data collection and 
requesting them to fill in the web- based questionnaires. 
If the questionnaires are not completed, the patient will 
receive a reminder after 1 and 2 weeks. After 2 weeks, non- 
responders will be contacted by phone.
Data management
Data from initial visits to the hospital, follow- up visits 
and questionnaires will be entered into a database via an 
electronic data system (Gemstracker). This data will be 
noted and analysed by using coded information (study 
numbers) without any personal identifiers. Data will be 
stored via the secure data management system of the trial 
coordination centre of the Erasmus MC.
Statistical analysis
Patient characteristics will be summarised per treatment 
group to determine whether the randomisation was 
balanced. Continuous variables will be presented using 
means and SDs, or in the case of non- normally distrib-
uted variables using medians and IQRs. Normality will 
be graphically assessed. Categorical variables will be 
Table 1 Participant timeline schedule
Table
Visit plan and case report forms
Intake
Surgery 
(t0)
1–2 day(s) 
following 
surgery
FU 3 
weeks
FU 6 
weeks
FU 3 
months
FU 6 
months
FU 12 
months
FU 18 
months
FU 24 
months
FU 36 
months
FU 48 
months
Visit surgeon x     x             
Research nurse visit x     x   x x x
Randomisation x                   
Surgery x                   
Discharge   x                 
Physical examination x     x   x x x
Functional X- rays x     x       x   
Roland- Morris 
Questionnaire
x   x x x x x x x x
Oswestry Disability Index x   x x x x x x x x
NRS leg and back pain x   x x x x x x x x
Patient self- received 
recovery and satisfaction
x   x x x x x x x x
EuroQol- 5D x   x x x x x x x x
Cost questionnaires x   x x x x x x x   
Short form 36 x   x x x x x x x x
Revisit and complications With occurrence
FU, follow- up; NRS, Numeric Rating Scale.
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presented using counts and percentages. The primary 
analysis will study differences in the primary outcome 
measure (RMDQ). The primary endpoint of interest is 
12 months after randomisation. The results of the RMDQ 
will be assessed using generalised linear mixed models 
(GLMM), to account for the repeated measurements 
within patients and the multicentre stratification.
The secondary outcomes (ODI, NRS leg and back 
pain score, TUG test, TCST and the SF-36) will be simi-
larly assessed using GLMMs and will be analysed for 
exploratory purposes. In all analyses the primary assess-
ment of treatment effect will be the estimate of the 
main effect within the appropriate model at 12 months, 
adjusted for the stratification factors and main covari-
ates. Time to recovery will be analysed using survival 
analysis (Cox proportional hazards). At 24, 36 and 48 
months, the GLMM repeated- measurement analyses 
using the compound symmetry covariance structure will 
be used while group (interarcuair and conventional), time 
(moments of measurement) and the interaction between 
group and time (grou×time) will be entered as indepen-
dent variables. Dependent variables are the primary and 
secondary outcome parameters. Likert scales for self- 
reported patient recovery and satisfaction will be assessed 
using descriptive statistics (counts and percentages) and 
appropriate plots. Comparisons of Likert scale results at 
individual time points will be tested using Mann- Whitney 
U tests. Complications and incidence of reoperations 
will be assessed using descriptive statistics (counts and 
percentages). Comparisons between treatment groups for 
specific complications of interest will be assessed using Χ2 
tests or Fisher’s exact tests. If necessary, missing data will 
be imputed using multiple imputation techniques.
Economic evaluation
An economic evaluation will be performed from the 
societal and healthcare perspectives to evaluate the cost- 
effectiveness of the bilateral interarcuair decompression 
compared with a ‘classic’ laminectomy for patients with 
INC. When the societal perspective is applied, all costs 
and consequences relevant to the interventions will be 
taken into account, whereas only costs accruing to the 
formal Dutch healthcare sector will be considered when 
the healthcare perspective is applied. Intervention costs 
will be estimated using a micro- costing approach. Cost 
questionnaires will be administered at 3, 6 and 12 weeks 
covering the entire period and at 6, 12, 18, 24, 36 and 
48 months after surgery covering the previous 3 months. 
Data will be collected on healthcare utilisation, the use 
of informal care, absenteeism, presenteeism and unpaid 
productivity losses. Costs will be valued using guideline 
prices recommended in the Netherlands.46
A cost- utility analyses will be conducted with QALYs as 
outcome. For estimating QALYs, the patients’ EQ- 5D- 5L 
health states will be converted into utility scores using the 
Dutch tariff.43 Linear interpolation between measure-
ment points will be used to subsequently calculate QALYs. 
Missing data will be imputed using multiple imputation 
by chained equations.47 An incremental cost- utility ratio 
will be calculated by dividing the difference in costs by 
the difference in effects. The cost- utility ratio expresses 
the incremental costs per QALY gained. Bootstrapping 
techniques will be used to estimate the uncertainty 
surrounding the cost- effectiveness estimates. Uncer-
tainty will be shown in cost- effectiveness planes and cost- 
effectiveness acceptability curves, and sensitivity analyses 
will be performed to test the robustness of the study 
results.
Data monitoring
This study will be monitored according to a detailed moni-
toring plan adapted to the risk classification of the Dutch 
University Federation guidelines. Based on this guide-
line, the risk classification of this study is regarded negli-
gible. Considerations in this assessment are that this is an 
investigator- initiated trial, not with vulnerable patients, 
and while side effects, such as nerve root damage, are 
known, severe adverse events (AEs) are extremely rare. 
Audits may be required by the Medical Ethical Committee 
or by the regulatory authority inspections and will be 
granted if necessary. Patients’ permission for these audits 
is obtained with informed consent.
ETHICS AND DISSEMINATION
Research ethics approval
This protocol, along with the informed consent forms, 
recruitment materials and other requested documents, 
was reviewed and approved by the Medical Ethical 
Committee of Erasmus MC in Rotterdam with respect 
to scientific content and compliance with applicable 
research and human subject regulations.
Protocol amendments
Any subsequent amendments will be reviewed and 
approved by the ethical review bodies.
Consent or assent
Surgeons will introduce the trial to patients at the outpa-
tient clinic and will hand them a patient information 
brochure regarding the main aspects of the trial. Patients 
will be given 5 working days to decide if they want to 
participate in the trial. Trained research nurses will call 
patients after 1 week to ask if they wish to partake in the 
trial. After verbal consent, an appointment will be made 
with the research nurse, where informed consent forms 
will be obtained (see online supplemental appendix 1).
Confidentiality
All study- related information will be stored securely at 
the study site. All participant information will be stored 
in locked file cabinets with limited access. All reports, 
data collection (eg, case report forms) and administrative 
forms will be entered into an online data system. All these 
documents will be identified by a coded study number 
only to maintain the patient confidentiality. These data 
will be stored for at least 15 years.
 on N
ovem
ber 13, 2020 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2020-036818 on 6 O
ctober 2020. D
ow
nloaded from
 
7Arjun Sharma J, et al. BMJ Open 2020;10:e036818. doi:10.1136/bmjopen-2020-036818
Open access
Ancillary and post-trial care
AEs and serious AEs will be monitored. SAE will be 
reported within 24 hours. The sponsor has an insurance 
which is in accordance with the legal obligations in the 
Netherlands. The insurance applies to the damage that 
becomes apparent during the study or within 4 years after 
the end of the study.
Dissemination policy
The final trial results will be communicated to the 
participants, healthcare professionals, professional 
organisations and relevant guideline committees in the 
Netherlands. The results will be published in an interna-
tional peer- reviewed open- access scientific journal. There 
are no publication restrictions.
DISCUSSION
In this article, a protocol for a multicentre patient and 
observer blinded RCT of the SIZE study is presented. 
Surgical treatment, such as laminectomy or interarcuair 
decompression, for LSS has been shown to reduce symp-
toms.10 11 Due to an abundance of surgical interven-
tions to treat LSS, the surgical management as of now, 
demonstrates a wide variety of preferred treatments by 
spine surgeons.48 To reduce this variety, there is a neces-
sity for RCTs, to create guidelines on the optimal treat-
ment for LSS.49 There is an ongoing trial that compares 
three surgical decompression techniques in patients with 
lumbar spinal stenosis. Yet, conventional laminectomy is 
not applied in this trial, which is still a frequently used 
surgical technique.48 50 A recent study compared the 
radiological and clinical results of bilateral interlaminar 
decompression and laminectomy.51 However, this study 
was a single- centre study, was not blinded, and did not 
include a computerised randomisation. Furthermore, 
there were no data regarding the cost- effectiveness of 
both surgical interventions. The direct and indirect costs 
of an intervention are important determinants, that have 
to be taken into account by the surgeon, during everyday 
decision- making. In the SIZE study, we intend to include 
an economic evaluation to estimate the cost- effectiveness 
and therefore acquire new information on this topic.
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